{"id":61467,"date":"2024-11-08T12:06:03","date_gmt":"2024-11-08T12:06:03","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/11\/08\/immunocore-to-present-at-upcoming-investor-conferences\/"},"modified":"2024-11-08T12:06:03","modified_gmt":"2024-11-08T12:06:03","slug":"immunocore-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"Immunocore to present at upcoming investor conferences"},"content":{"rendered":"<div>\n<p align=\"left\">(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 8 November 2024) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jkAwPYQ6O8SPGBsZoV_fPpuSnL6e4yFfuyJi8X6ZwtRJBTrTF5DCi7laH8Jdzvjzv3K_N7CY37AEqpxKxYCF6gsRILLyohLURfNUZRAarSMkPh1igj9mFumac1lj7h8ICqyI7IpgIf6yWCLD0Hx-knjZmtk2bLmxZs8HNVqT6hrJJ50S_Hk3x2v1wALQ51-I\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)\">Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d)<\/a>, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in November.<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Guggenheim Securities Healthcare Innovation Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Tuesday, November 12, 2024, at 1:00 p.m. EST<\/p>\n<p align=\"justify\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<strong>Jefferies London Healthcare Conference <\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fireside Chat: Wednesday, November 21, 2024, at 9:00 a.m. GMT<\/p>\n<p align=\"justify\">The presentations will be webcast live and can be accessed by visiting \u2018Events &amp; Presentations\u2019, under \u2018Events\u2019, via the \u2018Investors\u2019 section of Immunocore\u2019s website at www.immunocore.com. Following the event, a replay of the presentations will be made available for a limited time.<\/p>\n<p align=\"justify\"><strong>About Immunocore<\/strong><\/p>\n<p align=\"justify\">Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX \u2013 Immune mobilizing monoclonal TCRs Against X disease \u2013 designed to treat a broad range of diseases, including cancer, autoimmune, and infectious disease. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The Company\u2019s most advanced oncology TCR therapeutic, KIMMTRAK has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.<\/p>\n<p align=\"justify\"><strong>Contact Information<\/strong><\/p>\n<p align=\"justify\"><strong>Immunocore <\/strong><\/p>\n<p align=\"justify\">S\u00e9bastien Desprez, Head of Communications<br \/>T: +44 (0) 7458030732<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8BJStYMNiumB_dhKobNWUh2anZamNeTVrqHDT93Dy7wFmSP30q1Ykdi8Nm1WFre_8qxA1XOHE48kdRbqOanQXocpPY1MjOn2ZJ1HEKPfDXdaEF3ibCQQrzIaz2ZKPF7fdaMNAYhwGzQ8RpPdV60vFw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>sebastien.desprez@immunocore.com<\/u><\/a><br \/>Follow on Twitter: @Immunocore<\/p>\n<p align=\"justify\"><strong>Investor Relations<\/strong><\/p>\n<p align=\"justify\">Clayton Robertson, Head of Investor Relations<br \/>T: +1 (215) 384-4781<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BNhZie3f62PDTCwjFprWMrW2russSvmU3i359IoJRJGNNEszLc_TFyLZmhd0Mq6DFEQMIS1zUpy0dxYsMEH42xx9E1uvxjh5AdT2qPvbB-c=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>ir@immunocore.com<\/u><\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/OGUyOTMzZGQtNjdmNy00ZDU4LWE1MjUtYzVkYTRiNDc5NWE3LTEyMTc4MTE=\/tiny\/Immunocore-Holdings-plc.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d or the \u201cCompany\u201d), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences [&#8230;]\n","protected":false},"author":1,"featured_media":61468,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Immunocore to present at upcoming investor conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunocore to present at upcoming investor conferences\" \/>\n<meta property=\"og:description\" content=\"(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-08T12:06:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Immunocore-Holdings-plc-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Immunocore to present at upcoming investor conferences\",\"datePublished\":\"2024-11-08T12:06:03+00:00\",\"dateModified\":\"2024-11-08T12:06:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\"},\"wordCount\":281,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\",\"name\":\"Immunocore to present at upcoming investor conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-11-08T12:06:03+00:00\",\"dateModified\":\"2024-11-08T12:06:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunocore to present at upcoming investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immunocore to present at upcoming investor conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Immunocore to present at upcoming investor conferences","og_description":"(OXFORDSHIRE, England &amp; CONSHOHOCKEN, Penn. &amp; GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (\u201cImmunocore\u201d","og_url":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-11-08T12:06:03+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/Immunocore-Holdings-plc-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Immunocore to present at upcoming investor conferences","datePublished":"2024-11-08T12:06:03+00:00","dateModified":"2024-11-08T12:06:03+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/"},"wordCount":281,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/","name":"Immunocore to present at upcoming investor conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-11-08T12:06:03+00:00","dateModified":"2024-11-08T12:06:03+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/immunocore-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Immunocore to present at upcoming investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61467"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61467\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61468"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}